{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T12:03:37Z","timestamp":1780229017156,"version":"3.54.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,31]]},"DOI":"10.7759\/cureus.109960","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T11:35:14Z","timestamp":1780227314000},"source":"Crossref","is-referenced-by-count":0,"title":["NDM-Producing Klebsiella pneumoniae and Multidrug-Resistant Enterococcus faecium Bacteremia: A Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Nikolaos Iason","family":"Davanellos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyxeni","family":"Stefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafail","family":"Giannas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Peichamperis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Paraskeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Global action plan on antimicrobial resistance. (2015). Accessed. May 17, 2026: https:\/\/www.who.int\/publications\/i\/item\/9789241509763."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","unstructured":"Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022, 399:629-55. 10.1016\/S0140-6736(21)02724-0","journal-title":"Lancet"},{"key":"ref3","article-title":"Carbapenem-Resistant Enterobacterales - Third Update","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2025","unstructured":"European Centre for Disease Prevention and Control (ECDC). Carbapenem-Resistant Enterobacterales - Third Update. ECDC, Stockholm, Sweden; 2025."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2012.03.003","article-title":"Carbapenem resistance in Enterobacteriaceae: here is the storm!","volume":"18","author":"Nordmann P","year":"2012","unstructured":"Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med. 2012, 18:263-72. 10.1016\/j.molmed.2012.03.003","journal-title":"Trends Mol Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis LS","year":"2012","unstructured":"Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012, 25:682-707. 10.1128\/CMR.05035-11","journal-title":"Clin Microbiol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the Enterococcus: beyond vancomycin resistance","volume":"10","author":"Arias CA","year":"2012","unstructured":"Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012, 10:266-78. 10.1038\/nrmicro2761","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2014.04.002","article-title":"Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms","volume":"17","author":"Mendes RE","year":"2014","unstructured":"Mendes RE, Deshpande LM, Jones RN. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Drug Resist Updat. 2014, 17:1-12. 10.1016\/j.drup.2014.04.002","journal-title":"Drug Resist Updat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"van Duin D","year":"2016","unstructured":"van Duin D, Bonomo RA. Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations. Clin Infect Dis. 2016, 63:234-41. 10.1093\/cid\/ciw243","journal-title":"Clin Infect Dis"},{"key":"ref9","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. (2025). https.\/\/www.eucast.org\/clinical_breakpoints."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167042","article-title":"Detection of a cfr(B) variant in German Enterococcus faecium clinical isolates and the impact on linezolid resistance in Enterococcus spp","volume":"11","author":"Bender JK","year":"2016","unstructured":"Bender JK, Fleige C, Klare I, et al.. Detection of a cfr(B) variant in German Enterococcus faecium clinical isolates and the impact on linezolid resistance in Enterococcus spp. PLoS One. 2016, 11:e0167042. 10.1371\/journal.pone.0167042","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli E","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, et al.. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018, 18:318-27. 10.1016\/S1473-3099(17)30753-3","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of Carbapenemase-producing Enterobacteriaceae","volume":"17","author":"Nordmann P","year":"2011","unstructured":"Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011, 17:1791-8. 10.3201\/eid1710.110655","journal-title":"Emerg Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01222-13","article-title":"Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence","volume":"58","author":"Falagas ME","year":"2014","unstructured":"Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother. 2014, 58:654-63. 10.1128\/AAC.01222-13","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac268","article-title":"Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa)","volume":"75","author":"Tamma PD","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022, 75:187-212. 10.1093\/cid\/ciac268","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv086","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello M","year":"2015","unstructured":"Tumbarello M, Trecarichi EM, De Rosa FG, et al.. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015, 70:2133-43. 10.1093\/jac\/dkv086","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin D","year":"2017","unstructured":"van Duin D, Doi Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence. 2017, 8:460-9. 10.1080\/21505594.2016.1222343","journal-title":"Virulence"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00580-11","article-title":"The clinical predictive value (or lack thereof) of the results of in vitro antimicrobial susceptibility tests","volume":"49","author":"Doern GV","year":"2011","unstructured":"Doern GV, Brecher SM. The clinical predictive value (or lack thereof) of the results of in vitro antimicrobial susceptibility tests. J Clin Microbiol. 2011, 49:S11-4. 10.1128\/JCM.00580-11","journal-title":"J Clin Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.1.462-463.2005","article-title":"Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002)","volume":"43","author":"Treitman AN","year":"2005","unstructured":"Treitman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J Clin Microbiol. 2005, 43:462-3. 10.1128\/JCM.43.1.462-463.2005","journal-title":"J Clin Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice LB","year":"2008","unstructured":"Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008, 197:1079-81. 10.1086\/533452","journal-title":"J Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/497449-ndm-producing-klebsiella-pneumoniae-and-multidrug-resistant-enterococcus-faecium-bacteremia-a-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T11:35:15Z","timestamp":1780227315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/497449-ndm-producing-klebsiella-pneumoniae-and-multidrug-resistant-enterococcus-faecium-bacteremia-a-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.109960","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,31]]}}}